Matinas BioPharma Holdings, Inc. (MTNB) Net income 2016–2025
Matinas BioPharma Holdings, Inc. (MTNB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$10.3MFY2025 · since FY2016: -$7.6M → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | +57.3% |
| FY2024 | -$24.3M | -5.7% |
| FY2023 | -$22.9M | -9.3% |
| FY2022 | -$21.0M | +9.8% |
| FY2021 | -$23.3M | -3.7% |
| FY2020 | -$22.4M | -29.2% |
| FY2019 | -$17.4M | -23.4% |
| FY2018 | -$14.1M | +9.1% |
| FY2017 | -$15.5M | -103.8% |
| FY2016 | -$7.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice